髓内弥漫性中线胶质瘤伴H3 K27M突变1例

doi:10.6040/j.issn.1671-7554.0.2020.0014

摘要/Abstract

摘要： 目的探讨髓内弥漫性中线胶质瘤伴H3K27M突变的临床特征及治疗方式。方法回顾性分析1例髓内弥漫性中线胶质瘤伴H3K27M突变的诊断及治疗过程,并对相关文献进行复习。结果予以手术切除肿瘤,肿瘤组织与脊髓边界不清,尤其是肿瘤与马尾粘连严重,难以完全剥离清除。结合肿瘤的组织学特征、免疫组化、分子检测,诊断为弥漫性中线胶质瘤伴H3K27M突变,符合WHO Ⅳ级。术后患者虽腰背部疼痛较前缓解,但预后极差,最终复发死亡。结合文献复习,该肿瘤主要见于儿童,也见于成人,预后普遍较差。该肿瘤主要浸润于丘脑、脑干和脊髓,也可发现在第三脑室、下丘脑、松果体和小脑。结论尽管现代医学有了长足发展,但对该肿瘤仍缺乏有效的治疗手段,2年的总生存率仍然低于10%。

关键词: 弥漫性中线胶质瘤, H3K27M突变, 脊髓

Abstract: Objective To explore the clinical characteristics and treatment of diffuse midline glioma with H3K27M mutation. Methods The diagnosis and treatment of a case of diffuse midline glioma with H3K27M mutation were retrospectively analyzed and relevant literature was reviewed. Results The tumor was resected. The boundary between tumor tissues and spinal cord was unclear. The adhesion between tumor and cauda equina was especially hard to strip. Based on the histological characteristics, immunohistochemistry and molecular identification, the tumor was diagnosed as WHO IV diffuse midline glioma with H3K27M mutation. Although the patients back pain was relieved after operation, the prognosis was very poor, and the patient finally died of relapse. Literature review indicated the glioma was primarily found in children and occasionally seen in adults with poor prognosis. The glioma mainly infiltrated the thalamus, brainstem and spinal cord, sometimes the third ventricle, hypothalamus, pineal body and cerebellum. Conclusion Effective treatment of the glioma remains to be explored in spite of advances in modern therapies. The glioma is universally fatal and the 2-year overall survival rate is below 10%.

Key words: Diffuse midline glioma, H3 K27M mutation, Spinal cord

中图分类号:

R739.4

徐继禧,陈伟健. 髓内弥漫性中线胶质瘤伴H3 K27M突变1例[J]. 山东大学学报 (医学版), 2020, 1(7): 96-101.

XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101.

参考文献 23

[1]	Wang K, Zhang S, Shi L, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary [J]. Acta Neuropathologica, 2016, 131(6): 803.
[2]	Solomon DA, Wood MD, Tihan T, et al. Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations [J]. Brain Pathology, 2016, 26(5): 569-580.
[3]	Chiang JC, Ellison DW. Molecular pathology of paediatric central nervous system tumours [J]. J Pathol, 2017, 241(2): 159-172.
[4]	Castel D, Philippe C, Calmon R, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes [J]. Acta Neuropathologica, 2015, 130(6): 815.
[5]	郭伟, 邢振, 林禹, 等. 弥漫性中线胶质瘤H3K27M突变型多模态MRI表现[J]. 中国医学影像技术, 2019, 35(2): 31-35. GUO Wei, XING Zhen, LIN Yu, et al. Multimodal MRI manifestations of diffuse midline glioma,H3 K27M mutant[J]. Chinese Journal of Medical Imaging Technology, 2019, 35(2): 31-35.
[6]	叶海, 何品, 孙艳花, 等. 弥漫性中线胶质瘤伴H3K27M突变四例报告并文献复习[J]. 影像诊断与介入放射学, 2018, 27(5): 46-49. YE Hai, HE Pin, SUN Yanhua, et al. Diffuse midline glioma with H3 K27M mutation:4 case reports and review of literature[J]. Diagnostic Imaging & Interventional Radiology, 2018, 27(5): 46-49.
[7]	Meyronet D, Estebanmader M, Bonnet C, et al. Characteristics of H3 K27M-mutant gliomas in adults [J]. Neuro Oncol, 2017, 19(8): 1127-1134.
[8]	Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria [J]. Neuro Oncology, 2015, 17(1): 160-166.
[9]	Sturm D, Witt H, Hovestadt V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma [J]. Cancer Cell, 2012, 22(4): 425.
[10]	Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors [J]. N Engl J Med, 2015, 372(26): 2499-2508.
[11]	Brat DJ, Verhaak RGW, Aldape KD, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas[J]. N Engl J Med, 2015, 372(26): 2481-2498.
[12]	Mackay A, Burford A, Carvalho D, et al. Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma [J]. Cancer Cell, 2017, 32(4): 520-537.
[13]	Sturm D, Bender S, Jones DT, et al. Paediatric and adult glioblastoma: multiform(epi)genomic culprits emerge[J]. Nat Rev Cancer, 2014, 14(2): 92-107.
[14]	Nikbakht H, Panditharatna E, Mikael LG, et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma [J]. Nat Commun, 2016, 7: 11185. doi: 10.1038/ncomms11185.
[15]	Buczkowicz P, Hoeman C, Rakopoulos, et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations [J]. Nat Genet, 2014, 46(5): 451-456.
[16]	Orillac C, Thomas C, Dastagirzada Y, et al. Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation [J]. Acta Neuropathol Commun, 2016, 4(1): 84. doi: 10.1186/s40478-016-0361-0.
[17]	Hochart A, Escande F, Rocourt N, et al. Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma [J]. Ann Clin Transl Neurol, 2015, 2(4): 439-443
[18]	Chamdine O, Gajjar A. Molecular characteristics of pediatric high-grade gliomas [J]. Cns Oncology, 2014, 3(6): 433-443.
[19]	Karremann M, Gielen GH, Hoffmann M, et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location [J]. Neuro Oncol, 2018, 20(1): 123-131.
[20]	梁博, 梁庭毓, 王芳, 等. 弥漫性中线胶质瘤伴H3 K27M突变的临床诊疗及预后分析[J]. 中国微侵袭神经外科杂志, 2019(7): 299-302. LIANG Bo, LIANG Tingshu, WANG Fang, et al. Clinical diagnosis,treatment and prognosis analysis of diffuse midline glioma with H3 K27M mutation[J].Chinese Journal of Minimally Invasive Neurosurgery, 2019(7): 299-302.
[21]	Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials [J]. Lancet Oncology, 2006, 7(3): 241.
[22]	Vanan MI, Eisenstat DD. DIPG in children-what can we learn from the past? [J]. Front Oncol, 2015, 5: 237. doi: 10.3389/fonc.2015.00237.
[23]	Bender S, Tang Y, Lindroth AM, et al. Reduced H3 K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas [J]. Cancer Cell, 2013, 24(5): 660-672.

相关文章 15

[1]	李鸿皓,于晶,陈亚丽,郭守刚. 20例NMOSD患者CD4⁺CD25⁺FoxP3⁺调节性T细胞数量和FoxP3 mRNA的表达水平[J]. 山东大学学报 (医学版), 2022, 60(4): 50-54.
[2]	冯宝民,王舟,徐晗,李佳存,于乔文,修建军. 抗髓鞘少突胶质细胞糖蛋白IgG抗体相关疾病临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(3): 45-50.
[3]	刘东,朱冬昀,彭长亮,张程,赵杰,高春正. 脊髓损伤修复的复合透明质酸水凝胶支架的构建及其评价[J]. 山东大学学报（医学版）, 2017, 55(9): 53-59.
[4]	陈磊,刘东晓,李开鸣,宋新强,曾宪思,蒋丽杰. 有序胶原材料联合CBD-BDNF对大鼠脊髓损伤的修复作用[J]. 山东大学学报（医学版）, 2017, 55(5): 43-48.
[5]	董金叶,林祥涛,曹金凤,吴勇,赵慧,谢辉辉,肖连祥. 16~42周胎儿脊髓颈膨大发育的MRI分析[J]. 山东大学学报（医学版）, 2016, 54(5): 74-78.
[6]	李红志,刘静,宋岩,迟令懿,刘玉光. 利拉鲁肽对脊髓损伤修复作用的探讨[J]. 山东大学学报（医学版）, 2016, 54(4): 1-5.
[7]	栾海辉,许巍,王牧川,吴林,王玲玲,马俊,刘艺鸣. 脊髓小脑性共济失调6型一家系临床、病理和分子生物学特点[J]. 山东大学学报（医学版）, 2016, 54(2): 63-67.
[8]	孙昊,汪春娟,王戈,王宝洁,郭守刚. 视神经脊髓炎谱系疾病伴常见非器官特异性自身抗体的特点[J]. 山东大学学报（医学版）, 2016, 54(10): 50-54.
[9]	王震,高计芳,关新媛,郭娟娟,杨笃晓,刘师莲. PC12细胞中V_d介导的SPHK1/S1P通路及其在EAE中的潜在功能[J]. 山东大学学报（医学版）, 2016, 54(10): 21-24.
[10]	邵飞, 张颖, 张立华, 边鹏飞, 刘冬晓, 李强. W135群脑膜炎奈瑟菌感染并垂体功能减退1例[J]. 山东大学学报（医学版）, 2015, 53(10): 94-96.
[11]	阳巧云, 李晶金, 李欢颜, 王波, 彭良玉, 旷昕. 慢性压迫性神经痛大鼠脊髓水平Reelin蛋白表达变化[J]. 山东大学学报（医学版）, 2014, 52(S1): 3-7.
[12]	简雯, 陈林云, 彭华斌, 漆学良, 涂怀军, 石庆之. 以急性脊髓圆锥病变为首发表现的淋巴瘤1例[J]. 山东大学学报（医学版）, 2014, 52(10): 111-112.
[13]	牟乐明1，孙占胜1，王伯珉1，高平2，初向全3. 骨髓间充质干细胞移植对脊髓损伤大鼠Toll样受体4表达的影响[J]. 山东大学学报（医学版）, 2014, 52(1): 37-41.
[14]	梁继业1,2,王翠兰1,邓小梅1. 急性单纯疱疹病毒性脑炎脑脊液可溶性凋亡相关因子的测定[J]. 山东大学学报(医学版), 2013, 51(11): 71-73.
[15]	李俊强1，郭继生1，王小岳1，王道光1，赵作辉2，杨静华1. ALS小鼠脊髓组织GFAP蛋白赖氨酸的乙酰化修饰[J]. 山东大学学报(医学版), 2013, 51(10): 15-18.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed